April 2nd, 2015

The First Tee Helps Lead Youth to a Brighter Future

Editor’s Note: As part of its longstanding commitment to children, Johnson & Johnson is the first Legacy Partner of The First Tee. The First Tee provides educational programs that build character, instill life-enhancing values and promote healthy choices through the game of golf. Today, we shine a spotlight on several current and former Johnson & Johnson employees who have volunteered their time with The First Tee and have seen firsthand how its programs positively impact children.


It’s tee time and Johnson & Johnson retiree Alfred Mays is set to enjoy the hobby he’s picked up in retirement – just not with the foursome you might expect. As an assistant coach and mentor with The First Tee of Savannah in Georgia, Alfred’s time on the course is often spent with young people who are learning life skills and leadership through the game of golf.

“I clearly see kids who have much more confidence in school, out of school and in work environments, based on their experience interacting with adults in The First Tee,” says Alfred, who retired in 2006 after 37 years with Johnson & Johnson. “The kids grow by leaps and bounds when they see that somebody cares about them and shares what the values learned in golf might mean as they get older.”

With The First Tee, Alfred found an incredible opportunity to combine his passion for the game of golf with his professional experience.

Read More

March 30th, 2015

In Motion at the American Academy of Orthopaedic Surgeons Meeting

By Michel Orsinger, Worldwide Chairman, Global Orthopaedics Group

I often say that the human body is meant to be in motion.

This week, the amazing technologies that make that possible, and the dedicated men and women who apply those technologies in orthopaedic surgery, were out in force at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS). DePuy Synthes was proud to be there as the world’s largest and most comprehensive orthopaedics company.

Three essential components work to keep bodies in motion: innovative solutions, dedicated surgeons, and supportive healthcare systems. Our DePuy Synthes Value Proposition recognizes the importance of each of them.

We brought INNOVATION to the AAOS meeting in the form of new products like TFN Advanced™ Femoral Nailing System, an advanced surgical nail system that helps patients who have fractured their hips. But we know it takes innovation beyond products, too. For example, we introduced surgeons to CareSense, an application that can help track patients’ progress throughout the orthopaedic treatment cycle. Every day, we bring innovation to hospital systems as we work to address the needs of surgeons as well as the cost and outcomes goals of healthcare networks.

2015 American Academy of Ortho

DePuy Synthes booth displays at the 2015 American Academy of Orthopaedic Surgeons meeting

This is the largest global meeting of orthopaedic surgeons each year – thousands and thousands of surgeons, many from outside the United States, come to participate in education and networking, and to see the new advances the orthopaedic industry is developing.

Read More

March 26th, 2015

#MuseumWeek and the Importance of Heritage

By Margaret Gurowitz, Chief Historian, Johnson & Johnson

#MuseumWeekThis week, thousands of museums and their fans across the world are celebrating #Museum Week. It’s an opportunity to use social media to engage people and get them excited about museums. Johnson & Johnson is proud to participate this year for the first time.

As the chief historian for Johnson & Johnson – and as a lifelong museum nerd – it’s not difficult to get me started on talking about the rich history of Johnson & Johnson and about our museum.   Since Johnson & Johnson was founded in 1886, our company has advanced health care and helped shape the modern world through innovations such as helping make surgery sterile, the first commercial first aid kits (1888) and first aid manuals (1901), trusted consumer products and maternal and child health kits to make childbirth safer (1894), the first premade commercial dressing for small wounds (1921), breakthrough medicines, community programs and much, much more.  Understanding our history is one of the best ways to understand Johnson & Johnson and the values that guide our company.

But our heritage is more than just a look back at the past: it’s a look at our present and future too.

Read More

March 25th, 2015

The Yin and Yang of Technology and Healthcare

By Kris Sterkens, Company Group Chairman, Janssen, the pharmaceutical companies of Johnson & Johnson, Asia Pacific

Earlier this month in Singapore, I had the privilege of speaking at the Healthcare Innovation Summit Asia, an annual event that evaluates the value of technology in improving health outcomes for our region. Both science and technology continue to have a positive impact on our lives while converging on so many levels, so it was a valuable opportunity to explore how this interconnectivity can deliver innovative solutions that address unmet medical needs.

Big Data is enabling our industry to process large amounts of unstructured data more efficiently than ever before, which is allowing our researchers to more quickly identify connections, causes and effects. We’re also seeing more opportunities with wearable devices to help patients manage chronic diseases. In Australia, we are partnering with a local company on the development of a wearable device to help predict falls in the elderly before they occur. As well as helping patients, this has the potential to reduce the enormous annual cost burden for injuries that are caused by falls in Australia.

But in an era defined by profound technological advances, the practice of medicine remains an art as well as a science.

Read More

March 24th, 2015

An End-to-End Approach to Advancing Medical Innovation

Last week, Dr. William Hait, Global Head, Janssen Research & Development, and  Member of the Research!America Board, published a guest blog post on ResearchAmerica.org where he underscored the importance of collaborating with key stakeholders to form an end-to-end approach to enhance critically needed research.

Dr. Hait emphasized that “solving complex research challenges requires more than individual effort. It also takes the willingness and skill to bring together government, academia and the private sector.”

He noted that innovative approaches that enhance the speed of medical innovation, combined with more robust U.S. federal funding of health research and new STEM education initiatives, “form an end-to-end approach that will enhance critically needed research, fostering a new generation of R&D talent, and incentivizing development of next-generation technologies. Collectively, they will help advance medical innovation for all to benefit.”

Read the full blog post here.

Bill HaitWilliam N. Hait is Global Head, Janssen Research & Development, LLC, the global research and development arm of Janssen, the pharmaceutical companies of Johnson & Johnson. In this role, he leads the global R&D group in its mission to discover and develop innovative new medicines to address the world’s most serious unmet medical needs.

Read More

March 23rd, 2015

The Bridge Over Troubled Waters

By Yvette Williams, Manager, Political Programs, Johnson & Johnson U.S. Government Affairs & Policy

My parents were from humble beginnings.  “Ma,” as I called her, was from North Carolina, and dad heralded from West Virginia.  They met in Washington, D.C., at a time when it was common for African-Americans to leave rural towns to pursue jobs in major cities.  Both were subject to Jim Crow laws that required separate accommodations for blacks and whites. Neither achieved a college degree.  However, both had a strong work ethic and common sense, which they passed on to me, in part by making sure I got a good education.

Sadly, neither one lived long enough to see our first African-American president take the oath of office – twice – but I think they would have been equally surprised to see their daughter join that president on March 7 in Selma, Alabama.

We were there to commemorate the 50th anniversary of “Bloody Sunday,” the day in 1965 when civil rights marchers trying to cross the Edmund Pettus Bridge were savagely beaten by the authorities. The events of Bloody Sunday led to the passage later that year of the Voting Rights Act of 1965, signaling the beginning of the end of racial discrimination at the ballot box.

Read More

March 20th, 2015

Balancing Act: Women Lose Without Safe Water

By Joy Marini, Executive Director, Corporate Contributions, Johnson & Johnson

As I approached the hanging latrine in Dhaka, Bangladesh, my first thoughts were “how am I going to get up there?” and then “where is the door?” I was in Dhaka to see the progress of a partnership begun in 2009 with Water.org and DSK, a Bangladesh-based water organization, and it was time for me to understand the impetus behind this project.

Hanging latrine in Karmrangir Char, Dhaka, Bangladesh. (Photo by Gary White/Water.org)

Hanging latrine in Karmrangir Char, Dhaka, Bangladesh. (Photo by Gary White/Water.org)

In Dhaka, and in many other parts of the world without toilets or clean water, people must navigate a precarious ramp, sometimes a single plank, to a raised outdoor toilet. Aside from the unsanitary conditions, lack of privacy and spread of disease, navigating a wobbly ramp is a balancing act that is often beyond the abilities of the very young and very old.

Wobbly ramps aren’t the only balancing acts people encounter when their communities lack clean water and sanitation – for women and girls, the biggest balancing act is time. Women and children, usually girls, spend 140 million hours a day collecting water. In the Dhaka community that I was visiting, a girl might spend 2-3 hours a day gathering clean water.

Read More

March 17th, 2015

Working Together on Alzheimer’s Disease

By Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

We all know a person with dementia or Alzheimer’s disease: a grandparent or friend, or we may have heard about someone famous who has been diagnosed. We have all heard stories from colleagues, or have our own experiences, with a family member who can no longer remember his children’s names, can no longer drive, and has trouble getting words out, and later on, needs help dressing. The gradual loss of cognition and ability to function slowly steals the person away and causes considerable suffering and hardship.

Approximately 44 million people worldwide suffer from dementia, and as the population ages, this number is expected to double by 2030 and more than triple by 2050. These are truly staggering projections, and the human aspects are heart-wrenching.

Johnson & Johnson and our Janssen pharmaceutical companies have never been more committed to helping people with dementia and Alzheimer’s disease. We recently announced an investment of $10 million through Johnson & Johnson Innovation – JJDC, Inc. in a new UK government-led dementia discovery fund that will support innovative research to prevent and treat these devastating conditions. We helped to create the fund as a new type of model to finance early, promising research, based on the reality that one company, one country, or one university cannot do it alone.

Read More

March 15th, 2015

Health Care Pros Build the Case for More Sustainable Hospitals

By Keith Sutter, Director, Medical Devices Sustainability, Johnson & Johnson

We know the impact of health care on our environment is huge: In the United States alone, it’s estimated that hospitals are responsible for generating more than 5.9 million tons of waste annually, and the health care sector is responsible for eight percent of the nation’s carbon footprint. The same can be said of the environment’s impact on health care. In her book, Greening Health Care, Kathy Gerwig of Kaiser Permanente cites a 2002 study that concluded social and environmental factors vastly outweigh medical care in determining people’s health.

It’s not difficult to understand why support for sustainability would be prevalent among health care professionals. In fact, a recent global Harris Poll survey commissioned by Johnson & Johnson found that more than three-quarters of health care professionals across six countries believe sustainability initiatives protect staff, and nearly 70% agreed they make business sense.

Support for Sustainability

Considered together, the data leads to an inevitable question:

How can health care professionals effectively make the case for investments in sustainability within their organization?

Answers are explored in a newly-released report from the Wharton-led Initiative for Global Environmental Leadership (IGEL) and Johnson & Johnson. Greener Hospitals: Building Consensus for Health Care Sustainability looks at best practices and challenges when it comes to developing, and communicating, the business case for sustainability investments across the health care industry.

Read More

March 14th, 2015

What am I doing for others today?

Editor’s note: At Johnson & Johnson, we occasionally like to share an ‘inside out’ perspective about our company and our employees. Recently, we hosted the “Helping Our Neighbors with Our Resources” (H.O.N.O.R.) Awards at our corporate headquarters in New Brunswick, New Jersey. These awards, in memory of Dr. Martin Luther King Jr., honor our employees and members of the local community who have demonstrated a passion for others through their caring and service, including their work with our company Employee Resource Groups (ERGs) and diversity and inclusion in general. (You can learn more about our ERGs here.)

One of the employees recognized at the event was Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson. Joaquin is the executive sponsor of the African-American Leadership Council, an Employee Resource Group at Johnson & Johnson. Below are excerpts from Joaquin’s remarks.


(left: Joaquin speaks at H.O.N.O.R Awards event) (right: Aisha C. Davies, Joaquin Duato, Matthew Johnson. Aisha and Matthew are co-chairs of the J&J H.O.N.O.R ERG)

Joaquin’s Remarks:

When I learned I was receiving this award for leadership and encouragement of the Employee Resource Groups at Johnson & Johnson, I was humbled. Martin Luther King Jr. is the epitome of a remarkable leader who changed the lives of millions.

Read More